More than 2 million people use Erowid every month...
but only 100 of those contribute financially.
If you use Erowid, PLEASE DONATE!

Erowid References Database

Kim SY, Anderson IB, Dyer JE, Barker JC, Blanc PD. 
“High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users”. 
Am J Drug Alcohol Abuse. 2007;33(3):429-38.
INTRODUCTION: Little is known about behaviors linked to gamma hydroxybutyrate (GHB) morbidity. METHODS: We surveyed 131 GHB users, using logistic regression to test the associations between the high risk behaviors and hospital treatment for GHB (26 [20%] of subjects).
RESULTS: Increased risk of GHB hospital treatment was associated with: co-ingestion of ethanol (OR 5.2; 95% CI 1.7-16), driving under the influence of GHB (OR 3.2; 95%, CI 1.3-7.8),use of GHB to treat withdrawal symptoms (OR 2.9; 95% CI 1.1-7.9), and co-ingestion of ketamine (OR 2.7; 95% CI 1.1-6.7).
CONCLUSIONS: Targeted prevention activities could focus on selected high-risk behaviors.
Notes # : erowid mention
Submit Comment
[ Cite HTML ] Plants & Drugs Mind & Spirit Freedom & Law Arts & Sciences Search About Erowid and Feedback Library & Bookstore Copyrights Memberships noref